Cowan Elvia 4
4 · Vaxcyte, Inc. · Filed Jul 9, 2024
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Cowan Elvia
SVP, FINANCE
Transactions
- Sale
Common Stock
2024-07-08$80.00/sh−5,000$400,000→ 12,723 total - Exercise/Conversion
Stock Option (right to buy)
2024-07-08−5,000→ 124,000 totalExercise: $25.92Exp: 2032-08-08→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2024-07-08$25.92/sh+5,000$129,600→ 17,723 total
Footnotes (3)
- [F1]Includes 567 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2024.
- [F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2023.
- [F3]1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.